Arteric Welcomes Kristen Giordano as Interactive Art Director

Arteric (http://arteric.com), a digital healthcare marketing agency that fuses exceptional software development skill with healthcare marketing expertise to help brands connect patients, caregivers and healthcare professionals with the health information and tools that enable patients to live longer, healthier lives is pleased to announce that Kristen Giordano has joined Arteric’s Creative Services team as an Interactive Art Director.

A graduate of New York’s School of Visual Arts, Kristen has helped transform strategic vision into award-winning websites, physician portals, interactive training materials and print materials for consumer and healthcare professional audiences. During Kristen’s near decade of increasing responsibility with Ogilvy CommonHealth, she created multichannel campaign assets that helped build and launch multiple brands, among them, Bydureon®(AstraZeneca), Skula®(Bayer), Xarelto®and Yondelis®(Janssen) and Flonase®(GSK).

“Competition is fierce for creative talent with a proven track record of exceptional design and UX (user experience design) skill applied to healthcare campaigns.” states Hans Kaspersetz, co-founder and president of Arteric. “Adding Kristen’s top-tier agency experience to our expanding Creative Services team further enhances our ability to create transformative experiences for our client’s healthcare brands and campaigns.”

Arteric’s Creative Director, Ross O’Shea, who worked previously with Ms. Giordano at Ogilvy CommonHealth, adds, “We’re very excited to have Kristen join the team. Her work ethic is like no other, and her exemplary design and user experience skill is already creating unique, transformative experiences for our clients.”

Mr. Kaspersetz adds, “Arteric’s mission is to help clients explore the boundaries of what’s possible. To do that, we search for people who aren’t afraid to step up, propose what hasn’t been done before and then find a way to make that happen. Kristen’s track record highlights her ability to do just that.”

Bydureon is a trademark of AstraZeneca Pharmaceuticals LP
Skyla are trademarks of Bayer Pharmaceuticals
Yondellis and Xarelto are trademarks of Janssen Pharmaceuticals, Inc.
Flonase is a trademark of GSK